NYSE:NVOPharmaceuticals
Following Buyback Update Is Novo Nordisk (NVO) Still Below Fair Value?
Share repurchase update gives investors fresh data point
Novo Nordisk (NVO) has updated investors on its ongoing share repurchase programme, with plans to buy back B shares for up to DKK 11.2 billion through 1 February 2027.
See our latest analysis for Novo Nordisk.
At a share price of $49.07, Novo Nordisk has seen a 30 day share price return of 11.83% and a 90 day share price return of 20.24%, yet its 1 year total shareholder return is down 24.60%. This suggests that recent momentum...